{"artifact":{"id":"wiki-researchers-asceneuron","artifact_type":"wiki_page","entity_ids":"[\"researchers-asceneuron\"]","title":"Asceneuron SA — OGA Inhibitor Biotech","quality_score":0.5,"created_by":"crosslink-migration","provenance_chain":"[]","content_hash":"9dcfdae5b1f12e197dfc7f25e00ae7bf531f759bfa4d467017a24263d0e3a96a","metadata":{"slug":"researchers-asceneuron","kg_node_id":null,"entity_type":"company","origin_type":"v1_polymorphic_backfill","source_table":"wiki_pages","wiki_page_id":"wp-a4c89177c088","__merged_from":{"merged_at":"2026-05-13","unprefixed_id":"researchers-asceneuron"},"_schema_version":1},"created_at":"2026-04-02T07:19:49-07:00","updated_at":"2026-04-02T13:40:08-07:00","version_number":5,"parent_version_id":null,"version_tag":null,"changelog":null,"is_latest":1,"lifecycle_state":"active","superseded_by":null,"deprecated_at":null,"deprecated_reason":null,"dependencies":null,"market_price":0.5,"origin_type":"internal","origin_url":null,"lifecycle_changed_at":"2026-04-02T13:40:08-07:00","citation_count":0,"embed_count":0,"derivation_count":0,"support_count":0,"contradiction_count":0,"total_usage":0.0,"usage_score":0.5,"usage_computed_at":null,"quality_status":"ok","contributors":[],"answers_question_ids":null,"deprecated_reason_detail":null,"deprecated_reason_code":null,"commit_sha":null,"commit_submodule":null,"last_mutated_at":"2026-05-16T14:51:34.657673-07:00","disputed_at":null,"gap_id":null,"mission_id":null,"intrinsic_priority":null,"effective_priority":null,"artifact_id":"22f27120-d02a-4f38-934c-f944489d99e8","artifact_dir":null,"primary_filename":null,"accessory_filenames":null,"folder_layout_version":1,"migrated_to_folder_at":null,"hypothesis_id":null,"authorship":{"kind":"human","contributors":[{"role":"author","actor_ref":"crosslink-migration"}]},"epistemic_tier":"T3_provisional","created_by_agent_id":null},"outgoing_links":[{"target_artifact_id":"wiki-biomarkers-csf-o-glcnac","link_type":"mentions","strength":0.4,"evidence":"Wiki 'Asceneuron SA — OGA Inhibitor Biotech' content mentions biomarker 'CSF O-GlcNAc — Target Engagement Biomarker for OGA Inhibitors'"},{"target_artifact_id":"wiki-diseases-alzheimers-disease","link_type":"mentions","strength":0.4,"evidence":"Wiki 'Asceneuron SA — OGA Inhibitor Biotech' content mentions disease 'Alzheimer's Disease'"},{"target_artifact_id":"hypothesis-h-4dd0d19b","link_type":"related","strength":0.4,"evidence":"Wiki 'Asceneuron SA — OGA Inhibitor Biotech' content mentions disease 'ALZHEIMER'S DISEASE'"},{"target_artifact_id":"hypothesis-h-b234254c","link_type":"related","strength":0.4,"evidence":"Wiki 'Asceneuron SA — OGA Inhibitor Biotech' content mentions disease 'ALZHEIMER'S DISEASE'"},{"target_artifact_id":"hypothesis-h-55ef81c5","link_type":"related","strength":0.4,"evidence":"Wiki 'Asceneuron SA — OGA Inhibitor Biotech' content mentions disease 'ALZHEIMER'S DISEASE'"},{"target_artifact_id":"analysis-SDA-2026-04-02-gap-tau-prop-20260402003221","link_type":"related","strength":0.5,"evidence":"Auto: transitive via hypothesis"}],"incoming_links":[{"source_artifact_id":"analysis-SDA-2026-04-02-gap-tau-prop-20260402003221","link_type":"related","strength":0.5,"evidence":"Reverse link"}],"current_artifact_id":"wiki-researchers-asceneuron","is_canonical":true,"supersede_chain":["wiki-researchers-asceneuron"]}